Loading…
Mammalian d-aspartyl endopeptidase: a scavenger for noxious racemized proteins in aging
The accumulation of d-isomers of aspartic acid ( d-Asp) in proteins during aging has been implicated in the pathogenesis of Alzheimer’s disease, cataracts, and arteriosclerosis. Here, we identified a specific lactacystin–sensitive endopeptidase that cleaves the d-Asp-containing protein and named it...
Saved in:
Published in: | Biochemical and biophysical research communications 2004-02, Vol.314 (3), p.730-736 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The accumulation of
d-isomers of aspartic acid (
d-Asp) in proteins during aging has been implicated in the pathogenesis of Alzheimer’s disease, cataracts, and arteriosclerosis. Here, we identified a specific lactacystin–sensitive endopeptidase that cleaves the
d-Asp-containing protein and named it
d-aspartyl endopeptidase (DAEP). DAEP has a multi-complex structure (MW: 600
kDa) and is localized in the inner mitochondrial membrane of mouse and rabbit, but DAEP activity was not detected in
Escherichia coli,
Saccharomyces cerevisiae, and
Caenorhabditis elegans. A specific inhibitor for DAEP was newly synthesized, and inhibited DAEP activity (IC
50, 3
μM), a factor of 10 greater than lactacystin on DAEP. On the other hand, the inhibitor did not inhibit either the 20S or 26S proteasome. |
---|---|
ISSN: | 0006-291X 1090-2104 |
DOI: | 10.1016/j.bbrc.2003.12.147 |